The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to once again join forces to present the International Cancer Immunotherapy Conference.

The programme will focus on “Translating Science into Survival” and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy. 

This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.

Session Topics

• Antigens and Vaccines
• Emerging Technologies
• Mechanistic Merging of Treatment Modalities
• Microbiota
• New Agents and Their Mode of Action
• New Checkpoints
• Non-Checkpoint Immunotherapies
• Tumour Microenvironment